---
title: "“Excellent” 24-month MOTIV BTK outcomes for bioresorbable scaffold use in below-the-knee lesions"
date: "2023-09-19T10:28:28.000Z"
publishedDate: "19 septembre 2023"
summary: "Presenting data from the MOTIV bioresorbable scaffold (Reva Medical) below-the-knee (BTK) trial during Saturday’s FIRST@CIRSE session at this year’s Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023 annual meeting (9–13 September, Copenhagen, Denmark), Thomas Rand (Klinikum Floridsdorf, Vienna, Austria) underlined the “promising future applications” of the device for the treatment of BTK arteries in [&#8230;] The post “Excellent&#8221; 24-month MOTIV BTK outcomes for bioresorbable scaffold use in below-the-knee lesions appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/firstcirse-excellent-24-month-motiv-btk-outcomes-for-bioresorbable-scaffold-use-in-below-the-knee-lesions/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-09-19-excellent-24-month-motiv-btk-outcomes-for-bioresorbable-scaffold-use-in-below-the-knee-lesions"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2023/09/MicrosoftTeams-image-63.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/firstcirse-excellent-24-month-motiv-btk-outcomes-for-bioresorbable-scaffold-use-in-below-the-knee-lesions/"
---

![“Excellent” 24-month MOTIV BTK outcomes for bioresorbable scaffold use in below-the-knee lesions](https://interventionalnews.com/wp-content/uploads/sites/13/2023/09/MicrosoftTeams-image-63.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/firstcirse-excellent-24-month-motiv-btk-outcomes-for-bioresorbable-scaffold-use-in-below-the-knee-lesions/*

## L’essentiel

Presenting data from the MOTIV bioresorbable scaffold (Reva Medical) below-the-knee (BTK) trial during Saturday’s FIRST@CIRSE session at this year’s Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023 annual meeting (9–13 September, Copenhagen, Denmark), Thomas Rand (Klinikum Floridsdorf, Vienna, Austria) underlined the “promising future applications” of the device for the treatment of BTK arteries in [&#8230;] The post “Excellent&#8221; 24-month MOTIV BTK outcomes for bioresorbable scaffold use in below-the-knee lesions appeared first on Interventional News .

## Lien source

https://interventionalnews.com/firstcirse-excellent-24-month-motiv-btk-outcomes-for-bioresorbable-scaffold-use-in-below-the-knee-lesions/
